{"disease":{"id":"chemotherapy-induced-peripheral-neuropathy-in-breast-cancer","name":"chemotherapy induced peripheral neuropathy in breast cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06711978","title":"Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a Randomized Controlled Trial: a Quality of Life Study in Cancer Survivors","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":66,"lead_sponsor_name":"Pusan National University Yangsan Hospital","has_results":false},{"nct_id":"NCT02129686","title":"A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT05368428","title":"Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":27,"lead_sponsor_name":"Emory University","has_results":false},{"nct_id":"NCT04205071","title":"Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancer","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Ohio State University Comprehensive Cancer Center","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}